Drug use surveillance of Takecab tablets for "Gastric ulcer, duodenal ulcer, and reflux esophagitis"
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Vonoprazan (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Reflux oesophagitis
- Focus Adverse reactions
- Sponsors Takeda
- 14 Jun 2016 New trial record
- 22 Mar 2016 Status changed from not yet recruiting to recruiting.